November 21, 2019
Stephen Hahn, President Trump's nominee for FDA commissioner, on Wednesday faced questions from lawmakers on the Senate Health, Education, Labor and Pensions Committee regarding drug shortages and prices, e-cigarette use, and more.
CMS on its Nursing Home Compare website has begun indicating when nursing homes have been cited for abuse violations, and while the move has been applauded by consumer advocates, some in the nursing home industry say the alerts are misleading.
Colorado officials on Friday released their final proposal for a state public health insurance option, but the Colorado Hospital Association is raising concerns.
November 20, 2019
Sens. Cory Booker (D-N.J.), Kamala Harris (D-Calif.), and Bernie Sanders (I-Vt.), who are competing for the 2020 Democratic presidential nomination, on Friday introduced a bill that would establish a new federal agency to regulate prescription drug prices.
HHS on Monday announced the rate of improper Medicare fee-for-service payments in fiscal year (FY) 2019 was at the lowest point since FY 2010.
FDA on Friday granted Pentax approval to market a duodenoscope with a sterile, disposable elevator—an innovation that reduces the number of parts that need to be cleaned and therefore could lower the odds of transmitting dangerous superbugs.
November 19, 2019
Hospitals and health insurers are criticizing the Trump administration's new rules that aim to increase price transparency in the U.S. health system—and four major hospital groups have threatened to file a lawsuit challenging the regulations.
President Trump decided not to sign off on a policy to ban U.S. sales of unapproved flavored e-cigarettes the night before his administration planned to announce the measure, an anonymous adviser to Trump told the Washington Post.
November 18, 2019
FDA for the first time has approved an experiment that involves temporarily transplanting pig tissue into humans, a move that experts say could lead to further developments in animal-to-human donations.
As demand for in vitro fertilization has grown, fertility clinics have developed supplementary procedures, or "add-ons," that are purported to increase the odds of success—but there is little evidence these add-ons actually work.
Advisory Board. All rights reserved.